Andlauer Competitors

Delisted . USA . 
Stock . Andlauer Healthcare Group
ANDHFDelisted Stock  USD 38.11  0.00  0.00%   
Andlauer Healthcare competes with CTT -, Bodycote Plc, Fuji, Clarkson PLC, and Aegean Airlines; as well as few others. Analyzing Andlauer Healthcare competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Andlauer Healthcare to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Andlauer Healthcare vs CZG - Correlation

Very poor diversification

The correlation between Andlauer Healthcare Group and CZGZF is 0.86 (i.e., Very poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Andlauer Healthcare Group and CZGZF in the same portfolio, assuming nothing else is changed.

Moving together with Andlauer Pink Sheet

  0.67GOOG Alphabet Class CPairCorr

Moving against Andlauer Pink Sheet

  0.79PBCRY Bank Central AsiaPairCorr
  0.72MSFT Microsoft Sell-off TrendPairCorr
  0.66AAPL Apple IncPairCorr
  0.56PTAIF PT Astra InternationalPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
38.1138.1138.11
Details
Intrinsic
Valuation
LowRealHigh
32.3732.3741.92
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Andlauer Healthcare. Your research has to be compared to or analyzed against Andlauer Healthcare's peers to derive any actionable benefits. When done correctly, Andlauer Healthcare's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Andlauer Healthcare.

Andlauer Healthcare Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Andlauer Healthcare and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Andlauer and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Andlauer Healthcare does not affect the price movement of the other competitor.

High positive correlations

CZGZF
+ 0.85
CKNHF
CZGZF
+ 0.77
KRRYF
CKNHF
+ 0.73
KRRYF
CZGZF
+ 0.67
BYPLF
CKNHF
+ 0.65
BYPLF
BYPLF
+ 0.53
KRRYF
  

High negative correlations

AGZNF
- 0.83
CKNHF
AGZNF
- 0.79
KRRYF
CZGZF
- 0.74
AGZNF
AGZNF
- 0.42
BYPLF
AGZNF
- 0.18
FMMFF
AGZNF
- 0.18
CTTOF

Risk-Adjusted Indicators

There is a big difference between Andlauer Pink Sheet performing well and Andlauer Healthcare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Andlauer Healthcare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
KRRYF  2.54  0.63  0.00  1.77  0.00 
 0.00 
 11.34 
(10.00)
 60.19 
CTTOF  0.36  0.03  0.00  0.13  0.00 
 0.00 
 0.00 
 0.00 
 9.86 
AGRUF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
BYPLF  0.50  0.25  0.00 (13.64) 0.00 
 0.00 
 0.00 
 0.00 
 16.86 
FMMFF  2.62  1.35  0.00 (3.14) 0.00 
 0.00 
 0.00 
 0.00 
 87.95 
OKAMF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
CKNHF  0.65  0.18  0.07  0.87  0.46 
(1.53)
 1.88 
(1.72)
 10.96 
MEITF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
AGZNF  0.12 (0.07) 0.00 (4.83) 0.00 
 0.00 
 0.00 
 0.00 
 2.86 
CZGZF  2.59  0.58  0.16 (3.31) 2.17 
(4.42)
 7.82 
(5.01)
 23.39 

Andlauer Healthcare Competitive Analysis

The better you understand Andlauer Healthcare competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Andlauer Healthcare's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Andlauer Healthcare's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ANDHF KRRYF CTTOF AGRUF BYPLF FMMFF CKNHF AGZNF CZGZF
 0.00 
 38.11 
Andlauer
 0.00 
 1.08 
Kerry
 2.36 
 8.69 
CTT
 0.00 
 14.30 
AGRUF
 0.00 
 10.05 
Bodycote
 87.95 
 31.05 
Fuji
 2.25 
 54.20 
Clarkson
 0.30 
 16.85 
Aegean
 0.00 
 34.53 
CZG
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Not too volatile
Very steady
Somewhat reliable
Somewhat reliable
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Weakest
Weakest
Soft
Weakest
Fair
Fair
Good
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Hazard
Hazard
Low
Hazard
Low
Low
Low
Low
Hazard
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Under Valued
Under Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Not Rated
Strong Buy
Not Rated
Strong Hold
Hold
Strong Buy
Strong Hold
Not Rated
Current Ratio
1.26
1.46
0.61
0.69
0.83
5.7
1.7
1.13
2.32
Net Asset
N/A
N/A
3.59 B
13.11 B
1.07 B
243.31 B
682.1 M
1.54 B
17.01 B
Profit Margin
19.24
0.0751
0.0452
0.0307
0.0915
0.13
0.12
0.0568
0.088
EBITDA
97.77 M
7.98 B
55.64 M
2.18 B
165.1 M
39.2 B
87.1 M
171.27 M
1.93 B
Operating Margin
16.59
0.0749
0.0685
0.039
0.13
0.18
0.16
0.0935
N/A
Current Valuation
1.75 B
14.94 B
2.49 B
1.52 B
1.51 B
1.05 B
823.02 M
824.25 M
967.82 M
Price To Book
9.56
N/A
2.32
6.37
1.47
0.77
2.27
1.86
3.15
Retained Earnings
N/A
N/A
N/A
N/A
214 M
117.39 B
135 M
N/A
N/A
Current Asset
N/A
N/A
N/A
N/A
182 M
110.14 B
190 M
N/A
N/A
Five Year Return
N/A
N/A
N/A
N/A
N/A
N/A
2.33
N/A
N/A
Beta
0.58
0.74
1.11
0.58
1.2
1.01
1.31
1.76
0.21
Number Of Employees
1.8 K
49.7 K
11.23 K
30
4.76 K
2.79 K
1.7 K
2.44 K
2 K
Shares Outstanding
N/A
1.7 B
138 M
107.4 M
191.46 M
96.45 M
30.63 M
90.17 M
33.74 M
Cash Flow From Operations
96.6 M
5.77 B
53.31 M
1.42 B
144.3 M
15.72 B
113.8 M
211.46 M
1.52 B
Annual Yield
N/A
N/A
0.0345
0.0746
0.0307
0.0484
0.0272
0.14
0.0434
Total Debt
194.5 M
14.26 B
339.92 M
90 M
157.8 M
65.76 M
N/A
343.7 M
4.97 B
Return On Equity
37.9
0.19
0.23
0.33
0.087
0.0967
0.18
0.24
0.2
Z Score
N/A
N/A
0.6
12.2
5.4
16.8
N/A
1.2
N/A
Return On Asset
9.46
0.0771
0.0104
0.0552
0.0488
0.0705
0.0888
0.0384
0.0548
Book Value Per Share
3.95
10.09
1.39
24.0
3.87
2269.76
12.26
4.0
N/A
Current Liabilities
N/A
N/A
N/A
N/A
179 M
11.28 B
141 M
N/A
N/A
Total Asset
N/A
N/A
3.59 B
13.11 B
1.07 B
243.31 B
682.1 M
1.54 B
17.01 B
Debt To Equity
0.52
0.66
3.51
0.4
0.21
0.045
0.13
3.48
1.29
Last Dividend Paid
N/A
0.78
0.12
N/A
0.2
75.0
0.86
N/A
N/A
Shares Owned By Institutions
60.29
3.77
23.0
11.48
78.97
35.51
56.69
7.55
2.81
Market Capitalization
N/A
3.19 B
541.21 M
1.61 B
1.53 B
1.86 B
1.14 B
846.19 M
893.59 M
Price To Earning
37.13
8.67
26.39
12.92
N/A
8.74
13.96
5.56
13.56
Price To Sales
N/A
0.0404
0.54
0.0504
2.13
0.0095
2.22
0.41
1.34
Net Income
94.81 M
7.94 B
38.4 M
1.02 B
59.5 M
21.19 B
50.1 M
4.91 M
760.46 M
Earnings Per Share
1.02
0.56
0.3
0.91
0.38
1.67
2.4
0.88
1.71
Shares Owned By Insiders
1.52
84.77
29.29
61.52
1.01
12.19
13.49
62.0
N/A
Revenue
492.7 M
92.34 B
813.5 M
27.75 B
615.8 M
148.13 B
443.3 M
674.83 M
10.69 B
Working Capital
N/A
N/A
N/A
N/A
3 M
98.86 B
49 M
N/A
N/A
Cash And Equivalents
25.05 M
9.32 B
1.01 B
1.09 B
36.2 M
63.18 B
237.7 M
582.58 M
N/A
Cash Per Share
0.6
5.16
6.97
10.18
0.19
655.08
7.79
6.46
N/A
Gross Profit
152.26 M
9 B
453.25 M
9.3 B
83.3 M
58.49 B
426.8 M
99.37 M
4.29 B
Day Typical Price
38.11
1.08
8.69
14.3
10.05
31.05
54.2
16.92
34.53
Accumulation Distribution
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.0123
N/A
Market Facilitation Index
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.21
N/A
Daily Balance Of Power
0.0
0.0
9.2 T
0.0
0.0
9.2 T
0
0.2381
0.0
Period Momentum Indicator
N/A
N/A
0.2
N/A
N/A
14.53
(1.25)
0.05
N/A
Rate Of Daily Change
1.0
1.0
1.02
1.0
1.0
1.88
0.98
1.0
1.0
Day Median Price
38.11
1.08
8.69
14.3
10.05
31.05
54.2
16.95
34.53
Price Action Indicator
N/A
N/A
0.1
N/A
N/A
7.27
(0.62)
(0.08)
N/A
Coefficient Of Variation
812.4
1080.84
2352.06
N/A
812.4
812.4
669.45
(672.68)
702.44
Mean Deviation
0.0071
2.54
0.3628
N/A
0.5032
2.62
0.646
0.1188
2.59
Jensen Alpha
(0.01)
0.634
0.0273
N/A
0.2465
1.35
0.1801
(0.07)
0.5832
Total Risk Alpha
(0.01)
0.1214
(0.06)
N/A
0.0913
0.5185
0.0923
(0.09)
0.2687
Sortino Ratio
N/A
N/A
N/A
N/A
N/A
N/A
0.0712
N/A
0.164
Downside Variance
N/A
N/A
N/A
N/A
N/A
N/A
3.52
N/A
9.78
Standard Deviation
0.0291
7.2
1.46
N/A
2.08
10.83
1.36
0.3808
4.09
Kurtosis
66.0
34.79
28.41
N/A
66.0
66.0
22.43
47.5
5.24
Potential Upside
N/A
11.34
N/A
N/A
N/A
N/A
1.88
N/A
7.82
Treynor Ratio
1.13
1.77
0.1264
N/A
(13.64)
(3.14)
0.8656
(4.83)
(3.31)
Maximum Drawdown
0.2367
60.19
9.86
N/A
16.86
87.95
10.96
2.86
23.39
Variance
8.0E-4
51.85
2.12
N/A
4.31
117.21
1.86
0.145
16.76
Market Risk Adjusted Performance
1.14
1.78
0.1364
N/A
(13.63)
(3.13)
0.8756
(4.82)
(3.30)
Risk Adjusted Performance
(0.17)
0.0835
0.0388
N/A
0.1054
0.1086
0.1246
(0.13)
0.1229
Skewness
8.12
5.05
(0.09)
N/A
8.12
8.12
3.66
(6.70)
1.7
Semi Deviation
N/A
N/A
N/A
N/A
N/A
N/A
0.4553
N/A
2.17
Information Ratio
(2.28)
0.0828
(0.01)
N/A
0.0894
0.1166
0.0981
(0.33)
0.1253
Value At Risk
N/A
(10.00)
N/A
N/A
N/A
N/A
(1.72)
N/A
(5.01)
Expected Short fall
N/A
N/A
N/A
N/A
N/A
N/A
(1.53)
N/A
(4.42)
Downside Deviation
N/A
N/A
N/A
N/A
N/A
N/A
1.88
N/A
3.13
Semi Variance
N/A
N/A
N/A
N/A
N/A
N/A
0.2073
N/A
4.73

Andlauer Healthcare Competition Performance Charts

Five steps to successful analysis of Andlauer Healthcare Competition

Andlauer Healthcare's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Andlauer Healthcare in relation to its competition. Andlauer Healthcare's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Andlauer Healthcare in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Andlauer Healthcare's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Andlauer Healthcare, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Andlauer Healthcare position

In addition to having Andlauer Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Recycling Thematic Idea Now

Recycling
Recycling Theme
West management companies as well as entities specializing in pollution control and recycling. The Recycling theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recycling Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Consideration for investing in Andlauer Pink Sheet

If you are still planning to invest in Andlauer Healthcare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Andlauer Healthcare's history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY